IndiaTickerGlenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · pdf
Source filing Company dossier
Glenmark Pharmaceuticals
NSE:GLENMARK · ISIN INE935A01035
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Glenmark Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Intimation Of Record Date For DividendBSE · corporate action · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - List Of OfficialsBSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Outcome for Board Meeting Outcome - Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Updates - Glenmark Pharmaceuticals LimitedNSE · investor presentation · pdf
Source filing Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Updates - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Record Date - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Glenmark Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Glenmark Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of Glenmark Pharmaceuticals Limited For The Quarter Ended June 30, 2026BSE · financial results · pdf
Archived filing Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing General Updates - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Glenmark Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Trading Window - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Investor Presentation - Glenmark Pharmaceuticals LimitedNSE · investor presentation · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing